Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo
Clinical trial NCT04811131 · TERMINATED
Trial details
- NCT number
- NCT04811131
- Sponsor
- Arcutis Biotherapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-04
- Primary completion
- 2021-08-09
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.